Coral Laboratories Limited has announced a board meeting on May 30, 2025, to approve the financial results for the quarter and financial year ended March 31, 2025. The board will also consider declaring the final dividend and appoint auditors for secretarial, internal, and cost functions for the fiscal year 2025-26. The trading window for the company’s equity shares remains closed from April 1, 2025, until 48 hours after the results announcement, ensuring compliance with insider trading guidelines. These decisions will impact governance and shareholder returns.